Abstract
The allele and genotype frequency distributions of polymorphic markers of the NOS1, NOS2, and NOS3 genes coding for three different NO synthases were compared for type 1 diabetes mellitus (T1DM) patients with or without diabetic polyneuropathy (DPN). The groups (total 180 patients, ethnic Russians or East Slavs from Moscow) had nonoverlapping (polar) phenotypes. Group DPN+ included patients with DPN and T1DM duration of no more than 5 years. Control group DPN- included patients without DPN and with T1DM duration of at least 10 years. No significant differences in allele and genotype frequency distributions were revealed for the polymorphic markers (CA) n of gene NOS1 (CCTTT) n of gene NOS2, and ecNOS4a/4b and Glu298Asp of gene NOS3, suggesting a lack of association between the polymorphic markers and DPN. In the case of the (CCTTT) n polymorphic marker of the NOS2 gene, a tendency toward an association with DPN was observed for allele 14. Carriers of this allele have a lower risk of DPN in T1DM.
Similar content being viewed by others
REFERENCES
Balabolkin M.I., Klebanova E.M., Kreminskaya V.M. 2001. Pathogenesis of angiopathies in diabetes mellitus. Sakharn. Diabet. 1, 5–11
Brownlee M. 2001. Biochemistry and molecular cell biology of diabetic complications. Nature. 414, 813–820.
Palmer R.M.J., Ferrige A.G., Moncada S. 1987. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327, 524–526.
Moncada S., Palmer R.M., Higgs E.A. 1991. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43, 109–142.
Cooke J.P., Tsao P. 1993. Cytoprotective effects of nitric oxide. Circulation. 88, 2451–2454.
Palmer R.M.J., Rees D.D., Ashton D.S., Moncada S. 1988. L-Arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem. Biophys. Res. Commun. 153, 1251–1256.
Knowles R.G., Moncada S. 1994. Nitric oxide synthases in mammals. Biochem J. 298, 249–258.
Hattori R., Sase K., Eizawa H., et al. 1994. Structure and function of nitric oxide synthases. Int. J. Cardiol. 47, 71–75.
Marsden P.A., Heng H.H.Q., Scherer S.W., et al. 1993. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J. Biol. Chem. 268, 17478–17488.
Xu W., Gorman P., Sheer D., et al. 1993. Regional localization of gene coding for human neuronal nitric oxide synthase (NOS1) to 12q24.2–24.31 by fluorescent in situ hybridization. Cytogenet. Cell Genet. 64, 62–63.
Hall A.V., Antoniou H., Wang Y., et al. 1994. Structural organization of human neuronal nitric oxide synthase gene (NOS1). J. Biol. Chem. 269, 33082–33090.
Grasemann H., Dazen J. M., Deykin A., et al. 1999. Simple tandem repeat polymorphisms in neuronal nitric oxide synthase gene in different ethnic populations. Hum. Hered. 49, 139–141.
Grasemann H., Yandava C.H., Storm van’s Gravesande K., et al. 2000. A neuronal NO synthase (NOS1) gene polymorphism is associated with asthma. Biochem. Biophys. Res. Commun. 272, 391–394.
Marsden P.A., Heng H.H.Q., Duff C.L., et al. 1994. Localization of the human gene for inducible nitric oxide synthase (NOS2) to chromosome 17q11.2–q12. Genomics. 19, 183–185.
Chartrain N.A., Geller D.A., Koty P.P., et al. 1994. Molecular cloning, structure and chromosomal localization of the human inducible nitric oxide synthase gene. J. Biol. Chem. 269, 6765–6772.
Xu W., Liu L., Empson P.C., et al. 1997. Evolution of a homopurine-homopyrimidine pentanucleotide repeat sequence upstream of the human inducible nitric oxide synthase gene. Gene. 204, 165–170.
Warpeha K.M., Xu W., Liu L., et al. 1999. Genotyping and functional analysis of a polymorphic (CCTTT)n repeat of NOS2A in diabetic retinopathy. FASEB J. 13, 1825–1832.
Johannesen J., Tarnow L., Parving H-H., et al. 2000. CCTTT-Repeat polymorphysim in the human NOS2-promoter confers low risk of diabetic nephropathy in type 1 diabetic patients. Diabetes Care. 23, 560–562.
Robinson L.J., Weremowicz S., Morton C.C., Michel T. 1994. Isolation and chromosomal localization of human endothelial nitric oxide synthase (NOS3) gene. Genomics. 19, 350–357.
Marsden P.A., Heng H.H.Q., Scherer S.W., et al. 1993. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J. Biol. Chem. 268, 17478–17488.
Miyahara K., Kawamoto T., Sase K., et al. 1994. Cloning and structural characterization of the human endothelial nitric-oxide-synthase gene. Eur. J. Biochem. 223, 719–726.
Shimasaki Y., Yasue H., Yoshimura M., et al. 1998. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J. Am. Coll. Cardiol. 31, 1506–1510.
Tsukada T., Yokoyama K., Arai T., et al. 1998. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem. Biophys. Res. Commun. 245, 190–193.
Wang X.L., Mahaney M.C., Sim A.S., et al. 1997. Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler. Thromb. Vasc. Biol. 17, 3147–3153.
Adachi T., Wang X.L. 1998. Association of extracellular-superoxide dismutase phenotype with the endothelial constitutive nitric oxide synthase polymorphism. FEBS Lett. 433, 166–168.
Voron’ko O.E., Chistyakov D.A., Shestakova M.V., et al. 1999. Polymorphism of endothelial NO synthase gene and genetic predisposition to nephropathy in insulin-independent diabetes mellitus. Sakharn. Diabet. 2, 2–3.
Zanchi A., Moczulski D.K., Hanna L.S., et al. 2000. Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney Int. 57, 405–413.
Strokov I.A., Novosadova M.V., Barinov A.N., Yakhno N.N. 2000. Clinical methods for estimating the severity of diabetic polyneuropathy. Nevrol. Zh. 5, 14–18.
Dyck P.J., Melton J.L., O’Brien P.C., Service F.G. 1997. Approaches to improve epidemiological studies of diabetic neuropathy: Insights from the Rochester Diabetic Neuropathy Study. Diabetes. 46, 5–8.
Komantsev V.N., Sabolotnykh V.A. 2001. Metodicheskie osnovy klinicheskoi elektroneiromiografii. Rukovodstvo dlya vrachei (Methodological Basis of Clinical Electroneuromyography: A Manual for Physicians). St. Petersburg.
Budowle B., Baechtel F.S. 1990. Modifications to improve the effectiveness of resrtiction fragment length polymorphism. Appl. Electrophor. 1, 181–187.
Hutchon D. http://Calculator for confidence intervals for odds ratio unmatched case control study.htm
Stockle J.-C., Muller B., Andiantsitokhoina R., Kleshchev A. 1998. Nitric oxide hyperproduction in vascular pathophysiology. Biokhimiya 63, 976–983.
Author information
Authors and Affiliations
Additional information
__________
Translated from Molekulyarnaya Biologiya, Vol. 39, No. 2, 2005, pp. 224–229.
Original Russian Text Copyright © 2005 by Zotova, Voron’ko, Bursa, Galeev, Strokov, Nosikov.
Rights and permissions
About this article
Cite this article
Zotova, E.V., Voron’ko, O.E., Bursa, T.R. et al. Polymorphic markers of the NO synthase genes and genetic predisposition to diabetic polyneuropathy in type 1 diabetes mellitus. Mol Biol 39, 200–205 (2005). https://doi.org/10.1007/s11008-005-0029-5
Received:
Issue Date:
DOI: https://doi.org/10.1007/s11008-005-0029-5